In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.
Ionis, Otsuka sign agreement for hereditary angioedema therapy
Share this article Ionis will be responsible for the non-clinical and clinical development of the product. Credit: Mongkolchon Akesin / Shutterstock.com. Ionis Pharmaceuticals has signed